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Mrg class G-protein-coupled receptors (GPCRs) are expressed exclusively in sensory neurons in the trigeminal and dorsal root ganglia.
Pharmacological activation of Mrg proteins is capable of modulating sensory neuron activities and elicits nociceptive effects. In this
study, we illustrate a controlmechanism that allows the Runx1 runt domain transcription factor to generate compartmentalized expres-
sion of these sensory GPCRs. Expression of MrgA, MrgB, and MrgC subclasses is confined to an “A/B/C” neuronal compartment that
expresses Runx1 transiently (or does not express Runx1), whereasMrgD expression is restricted to a “D” compartment with persistent
Runx1 expression. Runx1 is initially required for the expression of allMrg genes. However, during late development Runx1 becomes a
repressor for MrgA/B/C genes. As a result, MrgA/B/C expression persists only in the Runx1 “A/B/C” compartment. In 446 mice, in
which Runx1 lacks the C-terminal repression domain, expression of MrgA/B/C genes is dramatically expanded into the Runx1 “D”
compartment.MrgD expression, however, is resistant to Runx1-mediated repression in the “D” compartment. Therefore, the creation of
Runx1 and Runx1 compartments, in conjunction with different responses ofMrg genes to Runx1-mediated repression, results in the
compartmentalized expression ofMrgA/B/C versusMrgD genes. Within theMrgA/B/C compartment,MrgB4-expressing neurons inner-
vate exclusively the hairy skin. Herewe found that Smad4, a downstream component of bonemorphological protein-mediated signaling,
is required selectively for the expression of MrgB4. Our study suggests a new line of evidence that specification of sensory subtypes is
established progressively during perinatal and postnatal development.
Key words: Runx1; nociceptors; Mrg class G-protein-coupled receptors; nociceptive ion channels and receptors; cell type specification;
dorsal root ganglia
Introduction
The mouse genome encodes 50 Mrg (also named Mrgpr/SNSR)
class G-protein-coupled receptors (GPCRs), 12 of which are ex-
pressed exclusively in the somatic sensory neurons located in the
trigeminal ganglia and dorsal root ganglia (DRG) (Dong et al.,
2001; Lembo et al., 2002; Choi and Lahn, 2003; Zylka et al., 2003;
Zhang et al., 2005; Burstein et al., 2006). These Mrg genes are
divided into four subclasses: A (MrgA1-A8), B (MrgB4 andB5), C
(MrgC11), and D (MrgD) (Zylka et al., 2003; Zhang et al., 2005).
In adult mice, these Mrg subclasses exhibit compartmentalized
expression, as indicated by the nonoverlapping expression of
MrgD with otherMrg genes (Dong et al., 2001; Zylka et al., 2003,
2005) (see below). Most interestingly,MrgD andMrgB4 neu-
rons innervate distinct peripheral targets, skin epidermis and the
hairy skin, respectively (Zylka et al., 2005; Liu et al., 2007). Phar-
macological activation of Mrg proteins is able to modulate neu-
ronal activities and evoke painful responses (Grazzini et al., 2004;
Cai et al., 2007; Crozier et al., 2007).However, how compartmen-
talized expression of Mrg genes is established during develop-
ment is poorly understood.
A series of recent studies has shown that the runt domain
transcription factor Runx1 plays a pivotal role in controlling the
development of sensory neurons, particularly those involved
with nociception (Theriault et al., 2005; Chen et al., 2006; Kramer
et al., 2006; Marmigere et al., 2006; Zhong et al., 2006;Woolf and
Ma, 2007; Yoshikawa et al., 2007). Runx1 is initially expressed in
most nociceptors (Levanon et al., 2002; Chen et al., 2006). Sub-
sequently, Runx1 expression is extinguished in most peptidergic
nociceptors (Chen et al., 2006), and persists primarily in nonpep-
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tidergic nociceptors (Chen et al., 2006; Kramer et al., 2006). Ge-
netic studies demonstrate that Runx1 is required for the expres-
sion of nearly two-dozen ion channels and receptors, including
the whole family ofMrg genes (Chen et al., 2006) (see Fig. 1).
In this study, we will illustrate a control mechanism that al-
lows Runx1 to establish compartmentalized expression for Mrg
class sensory GPCRs. Accordingly, expression of MrgA, MrgB,
and MrgC subclasses is confined to an “A/B/C” neuronal com-
partment that expresses Runx1 transiently (or does not express
Runx1), whereasMrgD expression is restricted to a “D” compart-
ment with persistent Runx1 expression.
Materials andMethods
Animals. The generation of Runx1 conditional mutant mice, Wnt1-Cre
transgenic mice, 446 mice, Smad4 conditional null mice, MrgD-GFP
mice and SNS-Cre transgenic mice has been described previously (Jiang
et al., 2000; Yang et al., 2002; Agarwal et al., 2004; Nishimura et al., 2004;
Growney et al., 2005; Zylka et al., 2005). The morning that vaginal plugs
were observed was considered as E0.5. PCR-based genotyping for condi-
tional null mice has been described previously (Chen et al., 2006). The
following primers were used for the MrgD-GFP mutant allele, 5-ATG
GTG AGC AAG GGC GAG GAG-3 and 5-TCG CGC TTC TCG TTG
GGG TCT TTG-3; for the MrgD-GFP wild-type allele, 5-ATG AAC
TCC ACT CTT GAC AG-3 and 5-CAC TGG TGT TTG TTG GGA
TG-3; for the 446 mutant allele, 5-TCG CTT TCA AGG TGG TGG
CA-3 and 5-TCC GGA GCC GTT GAG AGT C-3; and for the wild-
type Runx1 allele, 5-TGTCTCTGCATCGCAGGACT-3 and 5-TGT
GCG TTC CAA GTC AGT TGT-3.
In situ hybridization and immunostaining. The in situ hybridization
(ISH) procedure and the probes used in this study have been described
previously (Chen et al., 2006). For ISH combined with anti-GFP fluores-
cent immunostaining, GFP was detected before the ISH procedure. Fro-
zen sections were dried at room temperature for 10min, postfixed in 4%
paraformaldehyde for 15 min, washed 3 times with PBS for 5 min each,
incubated with anti-GFP primary antibody (1:500 in PBT; Invitrogen,
Carlsbad, CA) for 30 min, washed three times with PBS for 5 min each,
and incubated with Alexa-488-conjugated secondary antibody (1:200 in
PBT; Invitrogen) for 30min. Note that all solutions were prepared under
RNase-free conditions. To avoid the masking of fluorescent signal by the
subsequent ISH dye signal, all sections were photographed by fluores-
cence microscopy, followed by regular ISH procedure using an alkaline
phosphatase (AP)-conjugated antibody (1:2000; Roche, Indianapolis,
IN) and 5-bromo-4-chloro-indolyl-phosphate/nitroblue–tetrazolium
(BCIP/NBT) substrates for development. The bright-field images of
opaque in situ signals were inverted into pseudo-fluorescent images, and
then merged with GFP fluorescent images.
ISH combined with anti-Runx1 (from Dr. Thomas Jessell, Columbia
University, New York, NY) or IB4 fluorescent staining has been de-
scribed previously (Chen et al., 2006), with the following modification.
Fluorescent signals of Runx1 and IB4 were photographed first, followed
by color development of ISH signals with BCIP/NBT substrates. The
bright-field images of ISH signals were inverted and then merged with
fluorescent images. As noted above, this sequential photographing
avoids the masking of low-level fluorescent signals by nonfluorescent
ISH signals, leading to a more sensitive detection of the coexpression of
Runx1 or IB4 with genes of interest. For example, in this study, we were
able to detect high or medium levels of Runx1 protein in virtually all
MrgD cells, whereas the previous procedure (in which ISH signals de-
veloped first, followed by Runx1 immunostaining) failed to show me-
dium levels of Runx1 expression in a fraction ofMrgD neurons (Chen
et al., 2006).
For double color ISH, two probes were labeled with fluorescein- or
digoxigenin-UTP. The probes were detected with peroxidase (POD)-
conjugated anti-digoxigenin antibody (1:400; Roche) and AP-
conjugated anti-fluorescein antibody (1:1000; Roche). The fluorescent
signal development for POD consists of three sequential amplification
steps: (1) TSA Biotin System (1:100; PerkinElmer, Wellesley, MA), (2)
Vectastain ABCKit (Vector Laboratories, Burlingame, CA), and (3) TSA
Fluorescein System (1:50; PerkinElmer). The fluorescent signals were
photographed, followed by development for AP with BCIP/NBT sub-
strates. The bright-field images of nontransparent purple signals were
inverted, and thenmerged with fluorescent images. Because the signal of
the second probe was developed with nonfluorescent BCIP/NBT sub-
strates, this modified double color ISH procedure is more sensitive than
the procedure that involves fluorescent substrates for both probes (Dong
et al., 2001; Zylka et al., 2003). For example, the colocalization ofMrgA3
and MrgB4 shown in this study was not detected in the previous study
(Zylka et al., 2003).
Cell counting.To compare total DRGneurons, T12 thoracic and L4/L5
lumbarDRGwere dissected from three pairs ofmutant and controlmice,
fixed, embedded, sectioned at 12mthickness.One of six adjacent sets of
sections was hybridized with the pan-neuronal probe SCG10, and the
number of SCG10 neurons was counted. Only cells containing nuclei
were counted. To determine the percentages of neurons expressing mo-
lecularmarkers, six adjacent sets of sectionswere prepared fromeachT12
DRG and probed separately with six different probes, one of which was
the pan-neuronal marker SCG10 so that percentages of DRG neurons
expressing a gene can be calculated. Four ormore independent T12DRG
or L4/L5 lumbar DRG were used for each counting. The difference be-
tween wild-type and mutant samples was subjected to a Student’s t test,
with p 0.05 considered significant.
Results
Loss ofMrg gene expression in conditional Runx1
null mutants
We recently reported that Runx1 is necessary for the expression
of two Mrg subclasses, class B (MrgB4 and MrgB5) and class D
(MrgD) (Chen et al., 2006). To determine whether Runx1 con-
trols the expression of class A (MrgA1-A8) and class C (MrgC11)
genes, we analyzed Runx1 conditional knock-out mice by cross-
ing floxed Runx1mice (Runx1F) withWnt1-Cre transgenic mice
(Jiang et al., 2000; Growney et al., 2005). We have previously
reported that in Runx1F/F;Wnt1-Cre mice [referred here to as
Runx1/(Wnt1)], Runx1 is removed in sensory precursors,
therefore representing a complete null mutation in nociceptors
(Chen et al., 2006). We found that expression of MrgA1-A8 was
eliminated in Runx1/(Wnt1) mice at every stage examined,
from embryonic day 16.5 (E16.5) to postnatal day 30 (P30) (Fig.
1A–F) (data not shown). High levels ofMrgC11 expression were
also eliminated in adult Runx1/(Wnt1) mice (Fig. 1H vs G,
arrow), but low levels of expression were independent of Runx1
(Fig. 1H vsG, arrowheads). We have previously shown that neu-
ronal survival is not affected in Runx1/(Wnt1) mice (Chen et
al., 2006). Therefore, the loss ofMrg gene expression is unlikely to
be caused by a loss of neuronal cells. Altogether, these data imply
a requirement of Runx1 for the expression of allMrg class GPCR
genes.
Compartmental expression ofMrg genes in adult DRG
To understand how Mrg gene expression is regulated, we exam-
ined in detail the cellular compartments that express Mrg sub-
classes by using double color in situ hybridizations. As reported
previously, adultMrgD neurons did not coexpressMrgA3 (Fig.
2A) or MrgB4 (Fig. 2B) (Dong et al., 2001; Zylka et al., 2005).
Here we found that the expression of two class A members,
MrgA3 andMrgA4, overlapped extensively with each other (Fig.
2C, arrows). Expression of MrgB4 was confined to neurons that
exhibited a low level of MrgA3 (Fig. 2D, arrows); neurons with
elevated MrgA3 expression did not coexpress MrgB4 (Fig. 2D,
arrowheads). It was reported that in adult DRG, elevatedMrgC11
expression is excluded from MrgD neurons (also see Fig. 3C),
but overlaps with MrgA3 neurons (Zylka et al., 2005). Consis-
tent with the restriction of MrgB4 expression to a subset of
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MrgA3 neurons, MrgB4 was expressed in a subset of MrgC11
neurons (Fig. 2E, arrows). Previous studies failed to detect a co-
expression ofMrgB4 withMrgA3 orMrgC11 (Zylka et al., 2005);
the discrepancy may be attributable to a difference in sensitivity
between using nonfluorescent substrates and fluorescent sub-
strates (see Materials and Methods)
In summary, neurons expressingMrg genes in adult DRG can
be divided into two compartments: the “D” compartment that
expressesMrgD and the “A/B/C” compartment that shows a par-
tially overlapping expression of MrgA, MrgB, and MrgC genes
(Fig. 2F).
Progressive segregation ofMrg expression compartments
We next asked when the segregation of the “A/B/C” and “D”
neuronal compartments emerges, by examining their expression
at early developmental stages.We found that robust expression of
MrgC11 andMrgDwas already detected at E16.5, whereas expres-
sion ofMrgA3 andMrgB4was initiated at P0 and P2, respectively
(Fig. 3A). To further examine the relationship amongMrg neu-
rons, we performed a transient fate-mapping experiment by us-
ing the MrgDGFP knock-in mice, in which the MrgD coding re-
gion is replaced by the gene for green fluorescent protein (GFP)
(Zylka et al., 2005). In adultMrgDGFP/ heterozygousmice, dou-
ble staining detected a complete overlap between GFP andMrgD
mRNA, suggesting that GFP expression can be used to faithfully
markMrgD neurons (Zylka et al., 2005) (data not shown).
In P2MrgDGFP/ heterozygous mice,96.3% (734 of 762) of
MrgD neurons, marked by GFP expression, coexpressed
MrgC11 (Fig. 3B).We also found that at P2
and P4, GFP protein was detected in 79.4%
(131 of 165) and 82.3% (51 of 62) of
MrgA3 and MrgB4 neurons, respec-
tively (Fig. 3D,F, arrows). Because adult
MrgA3 and MrgB4 neurons coexpress
MrgC11 (Fig. 2), we concluded that most
Mrg neurons at early developmental
stages coexpress MrgD and MrgC11. By
P30, GFP protein, however, can no longer
be detected in MrgA3, MrgB4 or
MrgC11 neurons in MrgDGFP/ het-
erozygous mice (Fig. 3C,E,G). These data
suggest that the “D” compartment retains
MrgD expression and extinguishesMrgC11
expression, and the “A/B/C” compartment
retains MrgC11 expression, extinguishes
MrgD expression, and acquires the expres-
sion of MrgA and MrgB genes (summa-
rized in Fig. 3H).
Dynamic Runx1 expressionmarks two
Mrg expression compartments
To gain insights into how Runx1 regulates
Mrg genes, we examined Runx1 expression
inMrg neurons at multiple developmen-
tal stages. Expression of MrgD was con-
fined predominantly to Runx1 neurons,
from P7 to P30 (Fig. 4A,B). Unexpectedly,
despite the loss of expression ofMrgA3 and
MrgB4 in Runx1/(Wnt1) mice, Runx1
protein was not detected in MrgA3 or
MrgB4 neurons at neonatal and adult
stages, including P2 and P4 when the ex-
pression of these two genes is actively be-
ing established (Fig. 4C–F ). It was reported previously that
Runx1 is expressed in most, if not all, nociceptors at E12.5-
E14.5, but is extinguished in 50% of nociceptors during
perinatal and postnatal development (Chen et al., 2006). The
simplest interpretation is that Runx1 is expressed transiently
in immature nociceptors that are fated to become MrgA3 or
MrgB4 neurons.
In summary, amongMrg neurons, persistent Runx1 expres-
sion marks the “D” neuronal compartment that expressesMrgD,
whereas Runx1 is probably expressed transiently in the “A/B/C”
compartment that expresses MrgA, MrgB, and MrgC subclasses
(Fig. 4G). However, it is possible that Runx1 might never be
expressed in some MrgA3 or MrgB4 neurons, thereby non-
autonomously controlling the expression of these sensoryGPCRs
(Fig. 4G). Previous studies show thatMrg neurons express Ret,
but not TrkA (Dong et al., 2001; Zylka et al., 2003). The lack of
Runx1 expression in MrgA/B/C neurons implies that Runx1-
negative cells include both TrkA neurons (Chen et al., 2006)
and Ret neurons.
446/446mice
Runx1 protein contains an N-terminal DNA-binding runt do-
main, a middle transcriptional activation domain, and a
C-terminal peptide VWRPY that is capable of binding the
Groucho class transcriptional repressor complex (Fig. 5A).
Runx1 therefore can act as either a transcriptional repressor or
activator (Durst and Hiebert, 2004). To determine whether
Runx1 repressor activity contributes to nociceptor phenotype
Figure 1. Loss of Mrg gene expression in Runx1 F/F; Wnt1-Cre mice [mentioned as Runx1 /(Wnt1) mice in text]. In situ
hybridizations with indicatedMrg probes were performed on sections through P30 T12 thoracic DRG.
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specification, including compartmental-
ized expression of Mrg genes, we ana-
lyzed 446mice (Nishimura et al., 2004).
446 encodes a truncated Runx1 protein
that lacks the C-terminal repression mo-
tif, the VWRPY peptide, but retains the
activation domain (Fig. 5A) (Nishimura
et al., 2004). In the 446 mutant allele,
the DNA sequence that encodes the trun-
cated 446 protein was inserted into the
Runx1 locus. As a result, the expression
of 446 is under the control of the en-
dogenous Runx1 promoter. Homozy-
gous 446/446 mutant mice survive to
adulthood (Nishimura et al., 2004). Total
neuron numbers in T12 thoracic DRG,
detected by the expression of the pan-
neuronal marker SCG10 (Stein et al.,
1988), were not affected by this Runx1
mutation, with 1244  53 per set of T12
DRG sections in 446/446 mice versus
1276  35 in wild-type mice ( p  0.27)
(see Materials and Methods). The num-
ber of DRG neurons that were labeled by
the isolectin B4 (IB4) of Griffonia sim-
plicifolia (Silverman and Kruger, 1988)
were also not changed, with 645 15 per
set of T12 DRG sections in 446/446
mice versus 643  16 in wild-type mice
( p  0.45).
Expression of the truncated 446 pro-
tein can still be detected by the anti-Runx1
antibody (Fig. 5B). Double staining of
446 and IB4 in T12 thoracic DRG re-
vealed that64.0 3.6% of IB4 neurons
expressed 446 in 446/446mice, which
was not different from 65.4  2.3% of
IB4 neurons that expressed the full-
length Runx1 protein in wild-typemice ( p 0.18). The percent-
ages of446 or Runx1 neurons that were labeled by IB4 were
also comparable, with 50.3  6.9% in 446/446 mice versus
46.4  2.7% in wild-type mice ( p  0.15). These data suggest
that deletion of the C-terminal repression domain affects neither
neuronal survival nor Runx1 expression.
Runx1 is required to suppress TrkA and the precursor gene
encoding the -CGRP protein in prospective nonpeptidergic
neurons (marked by the staining of IB4), as indicated by the
derepression of these two genes in Runx1/(Wnt1) mice (Chen
et al., 2006; Yoshikawa et al., 2007). Expression of TrkA and
-CGRP, however, was not expanded in IB4 neurons in 446/
446 mice (supplemental Fig. 1, available at www.jneurosci.org
as supplementalmaterial). These data suggest that theC-terminal
repression domain is not involved with Runx1-mediated sup-
pression of TrkA and -CGRP.
Expression of a set of ion channels and receptors, which is
eliminated in conditional Runx1 null mice (Chen et al., 2006),
was also not affected in446/446mice, including TRP channels
(TRPA1, TRPM8, and TRPC3), the ATP-gated channel P2X3, the
sodium channel (SNS2/Nav1.9), and the GDNF receptor Ret
(supplemental Figs. 1, 2, available at www.jneurosci.org as sup-
plementalmaterial), implying that Runx1-mediated activation of
these nociceptive molecules does not operate through the
C-terminal repression domain.
Expansion ofMrgA/B/C gene expression in446/446mice
We next examined the expression of Mrg genes in 446/446
mice.We found that the expression of class A, B and CMrg genes
was dramatically expanded in adult thoracic DRG of 446/446
homozygous mice, including MrgA2-A7, MrgB4, MrgB5, and
MrgC11 (Fig. 6A) (data not shown). The percentage ofMrgA3
neurons in P30 T12 thoracic DRG increased from 4.2  0.6 in
wild-type mice to 30.1  1.5 in 446/446 mice, a 7.2-fold in-
crease ( p  0.0006). Similarly, the percentage of MrgA4 neu-
rons increased from 4.0  0.1–28.0  3.0, a 7.0-fold increase
( p 0.003), the percentage ofMrgB4 neurons increased from
2.9  0.8–19.4  1.7, a 6.7-fold increase ( p  0.004), and the
percentage of MrgC11 neurons increased from 4.2  0.6–
32.3  1.2 ( p  0.0002) (Fig. 6B). An expansion of MrgA3 and
MrgB4 expression was also observed in lumbar DRG (supple-
mental Fig. 3, available at www.jneurosci.org as supplemental
material). In contrast, we did not observe increased expression of
MrgD, the most abundantly expressed family member. In fact,
the percentage of MrgD neurons was slightly but significantly
reduced, from 31.1  1.4 in wild-type mice to 23.9  0.4 in
446/446 mice ( p  0.005) (Fig. 6A,B). These data suggest
that, during removal of the Runx1 repressor domain, there is a
selective expansion of neurons that expressMrgA/B/C genes.
We next determined when the derepression ofMrgA3,MrgB4
and MrgC11 expression was established, by examining their ex-
Figure 2. Compartmental expression ofMrg genes.A–E, Double color in situ hybridizationswith indicated probes on sections
through P30 T12 thoracic DRG of wild-typemice. F, Schematics of twoMrg compartments. The “A/B/C” compartment expresses
MrgA3/A4 (“A”), MrgB4 (“B”), and MrgC11 (“C”) in a partially overlapping manner, and the “D” compartment expresses MrgD
(“D”).
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pression at multiple developmental stages. In wild-type mice,
expression of MrgA3 and MrgB4 started at P0 and P2, respec-
tively, and reached peak levels at approximately P4 (Fig. 6C). In
446/446mice, onset ofMrgA3 andMrgB4 expression was also
established at P0 and P2, respectively (Fig. 6C). Expansion of
MrgA3 expression occurred from P2 to beyond P7, and from P4
to beyond P7 forMrgB4 (Fig. 6C), implying a progressive activa-
tion of these GPCR genes. The lack of precocious expression in
446/446 mice also suggests that the late onset of MrgA3 and
MrgB4 expression in wild-typemice is not attributable to Runx1-
mediated repression at embryonic stages. Instead, the activator
activity for these GPCR genes is established progressively during
neonatal development.
In wild-type mice, MrgC11 expression is extinguished from
MrgD neurons from P2 to adulthood (Fig. 3). In 446/446
mice, the numbers ofMrgC11neurons inT12 thoracicDRGdid
not exhibit gross reduction at stages from P2 to P7 to P30 (Fig.
6C), implying that Runx1 repression domain is required for post-
natal extinguishment ofMrgC11 expression (see also below).
Expansion ofMrgA/B/C expression in446/446mice is
confined to the IB4;MrgD neuronal compartment
We next asked which population of neurons shows derepression
of these GPCR genes in 446/446 mice. In wild-type thoracic
DRG, MrgA3 and MrgC11 were expressed
in both IB4 and IB4 neurons (Fig.
7A,E, arrows vs arrowheads), whereas
MrgB4 (Fig. 7C) and MrgD (Dong et al.,
2001) are expressed exclusively in IB4
neurons. In446/446 homozygous mice,
double staining of IB4 and Mrg mRNAs
showed that expansion of MrgA3, MrgB4
and MrgC11 expression was confined to
IB4 neurons (Fig. 7B,D,F). The percent-
age of IB4 neurons expressingMrgA3 in-
creased from 8.2 1.4 in wild-typemice to
74.7  1.2 in 446/446 mice ( p 
0.0001), that ofMrgB4 neurons increased
from 6.9  1.2–37.4  8.0 in 446/446
mice ( p  0.02), and that of MrgC11
neurons increased from 9.7  1.2–81.4 
3.5 ( p  0.02) (Fig. 7G). However, the
numbers of MrgA3, MrgA4, or
MrgC11 neurons in the IB4 compart-
ment were not significantly changed (data
not shown). Expansion of MrgA3 and
MrgB4 expression in lumbar DRGwas also
confined to IB4 neurons (supplemental
Fig. 3, available at www.jneurosci.org as
supplemental material). The percentage of
MrgDneurons in T12 thoracic IB4neu-
ronal population, however, is slightly but
significantly reduced, from 81.6  1.0 in
P30 wild-type mice to 68.5 1.7 in 446/
446mice ( p 0.005) (Fig. 7G).
In wild-type DRG, themajority of IB4
neurons express MrgD, and these MrgD
neurons normally donot coexpressMrgA3,
MrgB4 or MrgC11 (Fig. 2) (Zylka et al.,
2003). In adult 446/446mice, nearly all
MrgD neurons in thoracic DRG coex-
pressedMrgA3 (Fig. 7H) andMrgA4 (data
not shown). Similarly, a portion ofMrgD
neurons coexpressedMrgB4 (Fig. 7I). In addition, because 81.4%
and 68.5% of IB4 neurons expressMrgC11 andMrgD, respec-
tively, we concluded that at least 49.9% [81.4-(100–68.5) 49.9]
of IB4 neurons coexpress MrgC11 and MrgD in adult 446/
446 mice. These results suggest that Runx1 actively suppresses
the expression ofMrgA/B/C genes inMrgD neurons. However,
we noted that a small number ofMrgA3 orMrgB4 cells lacked
MrgD expression in 446/446 mice (Fig. 7H, I, arrowheads).
The simplest interpretation is that in 446/446 mice, MrgD
expression is not expanded into the prospective “A/B/C” com-
partment that normally lack persistent Runx1 expression.
In summary, removal of the C-terminal Runx1 repression do-
main leads to a unidirectional expansion ofMrgA/B/C genes into
the “D” neuronal compartment.
Discussion
Mechanism of compartmentalized expression of Mrg class
sensory GPCRs
Our studies suggest a model that leads to compartmentalized
expression of Mrg genes. This model contains two key compo-
nents. First, Runx1 is initially expressed in most embryonic no-
ciceptors at E12.5-E14.5, but is extinguished in 50% of cells
during perinatal/postnatal development (Chen et al., 2006), lead-
ing to the creation of Runx1 and Runx1 neuronal compart-
Figure 3. Progressive segregation ofMrg compartments. A, In situ hybridizations on sections through T12 thoracic wild-type
DRG at indicated stages and the schematics for the onset of expression ofMrggenes.B–G, Double staining of GFP protein (green)
and Mrg mRNA (red) on sections through thoracic DRG at various stages of MrgD GFP/ heterozygous mice. H, Schematics for
progressive compartmental segregation ofMrg gene expression.
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ments. Second, different Mrg family members exhibit different
responses to Runx1-mediated repression. Runx1 is initially re-
quired for the expression of all Mrg genes, but at an undefined
developmental stage Runx1 becomes a repressor of MrgA/B/C.
Accordingly, expression ofMrgA/B/C is confined to the Runx1
“A/B/C” compartment, and is actively suppressed in the Runx1
“D” compartment. During removal of the Runx1 repressor do-
main in 446/446 mice, the truncated Runx1 protein is con-
verted into an activator, leading to a dramatic expansion ofMrgA
and MrgB expression in the “D” compartment. The truncated
446 protein is required for the expansion because a null muta-
tion in Runx1/(Wnt1) mice leads to a loss, rather than an
expansion, of MrgA and MrgB expression. MrgC11 is initially
expressed in the “D” compartment. Subsequent extinguishment
of MrgC11 expression in this compartment relies on Runx1-
mediated repression. Expression ofMrgD, however, is essentially
insensitive to Runx1-mediated repression, thereby allowing sus-
tained MrgD expression in the Runx1 “D” compartment. In
summary, the selective extinguishment of Runx1 is critical for the
establishment of the “A/B/C” compartment (by avoiding Runx1-
mediated suppression of MrgA/B/C genes at late developmental
stages), whereas persistent Runx1 expression allows a singular
MrgD expression in the “D” compartment (by actively suppress-
ing MrgA/B/C expression and possibly maintaining MrgD
expression).
A few outstanding issues remain to be solved. First, Runx1
protein is not detected inMrgA3 orMrgB4 neurons at neona-
tal stages, raising the question about whether Runx1 indirectly or
even non-autonomously controls the expression of these GPCR
genes. Second, the signal that is responsible for Runx1 extin-
guishment in the “A/B/C” compartment is unknown. Third, it
should be noted that in rat DRG, MrgA and MrgD gene expres-
sion overlaps extensively (Zylka et al., 2003), mimicking the ex-
pression pattern present in446/446mice. The mechanism for
species-specific expression pattern is unclear. One attractive pos-
sibility is that the ratMrgA promoter loses the capacity to bind to
the Runx1 repressor complex, leading to a concurrent Runx1-
mediated activation ofMrgA andMrgD genes.
Runx1 uses distinct pathways to suppress gene expression
in nociceptors
Runx1 is required to suppress several peptidergic neuron mark-
ers in IB4 nonpeptidergic nociceptors, including TrkA and
CGRP (Chen et al., 2006; Yoshikawa et al., 2007). Here we found
that Runx1 also actively suppressesMrgA/B/C genes in these neu-
rons. Interestingly, Runx1 uses distinct mechanisms to suppress
these two categories of genes. Runx1-mediated suppression of
MrgA/B/C, but not TrkA/CGRP, is dependent on the C-terminal
repression domain that is known to interact with the Groucho-
repressor complex (Durst and Hiebert, 2004; Nishimura et al.,
2004). Removal of this repression domain in 446/446 mice
leads to a derepression ofMrgA/B/C (Figs. 6, 7), without causing
a concurrent derepression of TrkA/CGRP in IB4 neurons (sup-
plemental Fig. 1, available at www.jneurosci.org as supplemental
material). In the immune system, Runx1 is able to use multiple
repression domains to suppress T cell receptor expression (Durst
and Hiebert, 2004; Telfer et al., 2004). Runx1 could in principle
use a different repression domain to suppressTrkA/CGRP. Alter-
natively, Runx1 may activate a downstream pathway that indi-
rectly suppresses peptidergic neuron markers. A support for the
latter scenario is the finding that Ret-mediated signaling is re-
quired for postnatal suppression ofTrkA in IB4neurons (Luo et
al., 2007). Accordingly, the loss of Ret expression after condi-
tional Runx1 knock-out may explain the derepression of TrkA
Figure 5. Sensory neuron development in446/446mice. A, Schematics for full-length
Runx1 protein and the truncated446 protein. The wild-type Runx1 protein (“Runx1”) con-
tains the DNA-bindingmotif “runt,” the activation domain “AD,” and the C-terminal repression
domain “RD.”446 is a truncated Runx1 protein that lacks the RD. B, Double staining of IB4
(red) and full-length or truncated Runx1 protein (green) on sections through T12 thoracic DRG
of wild-type and446/446mice.
Figure 4. Dynamic Runx1 expressionmarks distinctMrg compartments. A–F, Double stain-
ing of Runx1 protein (green) andMrgmRNAs (red) on sections through thoracic wild-type DRG
at various stages. G, Schematics for the origin of Mrg compartments. Runx1 expression in im-
matureMrgA/B/C neurons is inferred from the fact that Runx1 is expressed inmost, if not all,
TrkA neurons at early embryonic stages (Chen et al., 2006), and TrkA signaling is required for
the expressionofmostMrggenes (Luoet al., 2007). However, it remains apossibility that Runx1
is never expressed in someMrgA/B/C neurons (the dashed line).
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and CGRP in Runx1/(Wnt1) mice
(Chen et al., 2006; Yoshikawa et al., 2007),
whereas a normal expression of Ret in
446/446 mice (supplemental Fig. 1,
available at www.jneurosci.org as supple-
mental material) may explain the lack of
TrkA derepression. Regardless, Runx1 op-
erates through distinct pathways to sup-
press peptidergic differentiation and
MrgA/B/C expression.
Progressive specification of sensory
neuron subtypes
Our studies, combined with a series of re-
cent studies, suggest that specification of
sensory subtypes is progressively estab-
lished during perinatal and postnatal de-
velopment. Most embryonic nociceptors
(and thermoceptors) initially express both
Runx1 and TrkA (Chen et al., 2006). To
our knowledge, there are no knownmolec-
ular markers that are able to divide TrkA
neurons into distinct subgroups at E12.5. It
is from E14.5 to postnatal stages that noci-
ceptors are progressively segregated into
Ret, TrkA and Ret;TrkA subclasses,
with persistent Runx1 expression is con-
fined to a portion of Ret neurons (Ben-
nett et al., 1996, 1998; Molliver et al., 1997;
Chen et al., 2006). Nociceptors that express
distinct profiles of TRP class thermal re-
ceptors also emerge during perinatal/post-
natal development (Hjerling-Leffler et al.,
2007). Here we further found that Mrg
sensory neurons initially coexpress MrgD
and MrgC11 at embryonic stages. During
postnatal development, future MrgC11
neurons extinguish MrgD and activate
MrgA and/or MrgB genes. Conversely, fu-
ture MrgD neurons switch off MrgC11,
leading to a mutually exclusive expression
ofMrgA/B/C andMrgD.
Intriguingly, MrgD afferents inner-
vate skin epidermis (Zylka et al., 2005),
whereasMrgB4 afferents innervate exclu-
sively the hairy skin (Liu et al., 2007). Such
topographically distinct innervation raises
the hypothesis that segregation of MrgD
and MrgB4 nociceptors might partly de-
pend on specific target-derived signals. In-
deed, Ret signaling is required for the ex-
pression of MrgB4 (and MrgA3), but not
MrgD (Luo et al., 2007). Hair follicles also
release other signaling molecules, such as
bone morphological proteins or BMPs
(Blanpain and Fuchs, 2006). Indeed, a con-
ditional knock-out of Smad4, encoding a
key component of BMP-mediated signal-
ing (Yang et al., 2002), is required selec-
tively for the expression ofMrgB4 (supple-
mental Fig. 4, available at www.jneurosci.
org as supplemental material). Future
studies will be directed to investigate how
Figure 6. Expansion of Mrg genes in 446/446 mice. A, In situ hybridizations with indicated Mrg probes on sections
through T12 thoracic DRG of P30 wild-type and446/446mice. B, Percentages ofMrg neurons in T12 thoracic DRG of P30
wild-type and446/446 mice (*p 0.005). C, MrgA3, MrgB4, and MrgC11 neuron numbers in T12 thoracic DRG of
wild-type and446/446mice at multiple developmental stages. Six adjacent sets of sections were prepared from each DRG,
and numbers of positive neurons in one of the six sets were presented.
Figure 7. Expansion ofMrgA3,MrgB4, andMrgC11 expression in IB4;MrgD neurons in446/446mice. A–F, Double
stainingof IB4 (A–F, green) andMrgA3mRNA(A,B, red),MrgB4mRNA(C,D, red) orMrgC11mRNA(E,F, red) on sections through
thoracic DRG of P30 wild-type and446/446mice. G, The percentage of IB4 neurons that expressMrgA3,MrgB4,MrgC11,
orMrgD in T12 thoracic DRG of P30wild-type and446/446 homozygousmice (*p 0.02; **p 0.005).H–K, Double color
in situ hybridization on sections through T12 thoracic DRG of P30 446/446 homozygous mice (H, I ) and P30 446/
heterozygous mice (J, K ).
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target-derived signals interface with intrinsic factors, such as
Runx1, in generating sensory cell diversity.
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